Acute myeloid leukemia with cuplike nuclei and intracytoplasmic inclusions following myelodysplastic syndrome

被引：3
作者：
Manabe, Masahiro [1 ]
Nakamura, Koji [2 ]
Nakamura, Junko [2 ]
Fukuyama, Tomoko [2 ]
Fukada, Erina [2 ]
Senzaki, Hideto [3 ]
Ohta, Kensuke [1 ]
机构：
[1] Saiseikai Nakatsu Hosp, Dept Hematol, Kita Ku, Osaka 5300012, Japan
[2] Saiseikai Nakatsu Hosp, Dept Lab, Osaka 5300012, Japan
[3] Saiseikai Nakatsu Hosp, Dept Pathol, Osaka 5300012, Japan
来源：
INTERNATIONAL JOURNAL OF HEMATOLOGY | 2009年 / 90卷 / 01期
关键词：
Acute Myeloid Leukemia; Myelodysplastic Syndrome; Normal Karyotype; Lamellar Body; Internal Tandem Duplication;
D O I：
10.1007/s12185-009-0362-x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：11 / 12
页数：2
相关论文
共 50 条
  • [21] Immunotherapy for myelodysplastic syndrome and acute myeloid leukemia: where do we stand?
    Spillane, David R.
    Assouline, Sarit
    EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (11) : 819 - 834
  • [22] THE TREATMENT OF ACUTE MYELOID-LEUKEMIA PRECEDED BY THE MYELODYSPLASTIC SYNDROME
    HAMBLIN, T
    LEUKEMIA RESEARCH, 1992, 16 (01) : 101 - 108
  • [23] Editorial: Immunobiology and immunotherapeutics in myelodysplastic syndrome and acute myeloid leukemia
    Patel, Shyam A.
    Isidori, Alessandro
    Cerchione, Claudio
    Aureli, Anna
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [24] Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients
    G Rossi
    AM Pelizzari
    D Bellotti
    M Tonelli
    S Barlati
    Leukemia, 2000, 14 : 636 - 641
  • [25] An effective chemotherapeutic regimen for acute myeloid leukemia and myelodysplastic syndrome in children with Down's syndrome
    Kojima, S
    Sako, M
    Kato, K
    Hosoi, G
    Sato, T
    Ohara, A
    Koike, K
    Okimoto, Y
    Nishimura, S
    Akiyama, Y
    Yoshikawa, T
    Ishii, E
    Okamura, J
    Yazaki, M
    Hayashi, Y
    Eguchi, M
    Tsukimoto, I
    Ueda, K
    LEUKEMIA, 2000, 14 (05) : 786 - 791
  • [26] An effective chemotherapeutic regimen for acute myeloid leukemia and myelodysplastic syndrome in children with Down's syndrome
    S Kojima
    M Sako
    K Kato
    G Hosoi
    T Sato
    A Ohara
    K Koike
    Y Okimoto
    S Nishimura
    Y Akiyama
    T Yoshikawa
    E Ishii
    J Okamura
    M Yazaki
    Y Hayashi
    M Eguchi
    I Tsukimoto
    K Ueda
    Leukemia, 2000, 14 : 786 - 791
  • [27] MDR1 GENE-EXPRESSION IN MYELODYSPLASTIC SYNDROME AND IN ACUTE MYELOID-LEUKEMIA EVOLVING FROM MYELODYSPLASTIC SYNDROME
    ZOCHBAUER, S
    GSUR, A
    GOTZL, M
    WALLNER, J
    LECHNER, K
    PIRKER, R
    ANTICANCER RESEARCH, 1994, 14 (3B) : 1293 - 1295
  • [28] TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome
    Niparuck, Pimjai
    Police, Pornnapa
    Noikongdee, Phichchapha
    Siriputtanapong, Kanchana
    Limsuwanachot, Nittaya
    Rerkamnuaychoke, Budsaba
    Chuncharunee, Suporn
    Siriboonpiputtana, Teerapong
    DIAGNOSTIC PATHOLOGY, 2021, 16 (01)
  • [29] Venetoclax: A New Partner in the Novel Treatment Era for Acute Myeloid Leukemia and Myelodysplastic Syndrome
    El-Cheikh J.
    Bidaoui G.
    Saleh M.
    Moukalled N.
    Abou Dalle I.
    Bazarbachi A.
    Clinical Hematology International, 2023, 5 (2-3) : 143 - 154
  • [30] Aberrant methylation of the RIZ1 gene in myelodysplastic syndrome and acute myeloid leukemia
    Mori, Naoki
    Yoshinaga, Kentaro
    Tomita, Kaori
    Ohwashi, Mari
    Kondoh, Toshiaki
    Shimura, Hanae
    Wang, Yan-Hua
    Shiseki, Masayuki
    Okada, Michiko
    Motoji, Toshiko
    LEUKEMIA RESEARCH, 2011, 35 (04) : 516 - 521
12345